Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q75QN2
UPID:
INT8_HUMAN
Alternative names:
Protein kaonashi-1
Alternative UPACC:
Q75QN2; B2RN92; Q5RKZ3; Q6P1R5; Q7Z314; Q9NVS6; Q9NWY7
Background:
Integrator complex subunit 8, also known as Protein kaonashi-1, plays a pivotal role in the transcription and processing of small nuclear RNAs (snRNA) U1 and U2. This protein is a component of the Integrator complex, which is crucial for the 3'-box-dependent processing of snRNAs and is associated with the C-terminal domain (CTD) of RNA polymerase II largest subunit (POLR2A).
Therapeutic significance:
The protein is implicated in a neurodevelopmental disorder characterized by cerebellar hypoplasia and spasticity, highlighting its potential as a target for therapeutic intervention in genetic disorders affecting neurodevelopment.